EU consults on uniform approaches to releasing info from marketing dossiers
This article was originally published in SRA
Executive Summary
The European Medicines Agency, along with the EU's Heads of Medicines Agencies, has proposed new measures that would ensure a uniform and consistent approach to allowing public access to information submitted by pharmaceutical companies in their marketing application dossiers1,2.